Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study-Reference-Cited by-同舟云学术

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study

Published:2019-03-05 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Sciascia Savino,Radin Massimo,Cecchi Irene,Rubini Elena,Scotta Anna,Rolla Roberta,Montaruli Barbara,Pergolini Patrizia,Mengozzi Giulio,Muccini Emanuela,Baldovino Simone,Ferro Michela,Vaccarino Antonella,Mahler Michael,Menegatti Elisa,Roccatello Dario

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Standardization of antiphospholipid antibody assays. Where do we stand?;Devreese;Lupus,2012

2. Standardization of antiphospholipid antibody testing–historical perspectives and ongoing initiatives;Willis;Semin Thromb Hemost.,2014

3. Antiphospholipid antibody testing and standardization;Devreese;Int J Lab Hematol.,2014

4. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature;Galli;Blood,2003

5. Subcommittee on lupus anticoagulant/phospholipid/dependent antibodies. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH;Devreese;J Thromb Haemost.,2014

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hughes syndrome: The discovery of the antiphospholipid syndrome;Medicina Clínica;2024-08

2. Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus;Medicines;2024-07-31

3. Management of Cardiovascular Complications in Antiphospholipid Syndrome: A Narrative Review with a Focus on Older Adults;Journal of Clinical Medicine;2024-05-23

4. Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation;Frontiers in Immunology;2024-03-14

5. Testing for the lupus anticoagulant: the good, the bad, and the ugly;Research and Practice in Thrombosis and Haemostasis;2024-03